Biotech and Delisting Risk From China’s Perspective with WisdomTree
May 19, 2022 at 18:30 PM EDT
Liqian Ren, Ph.D., and director of modern alpha for WisdomTree, spoke with Dr. Peter Luo, Ph.D., co-founder and CEO of Adagene, regarding developments in the pharmaceutical industry and business practices abroad in the most recent China of Tomorrow podcast from WisdomTree. Adagene is a biotech...